MegaMD Co. Ltd (133750) - Total Liabilities

Latest as of December 2025: ₩16.86 Billion KRW ≈ $11.43 Million USD

Based on the latest financial reports, MegaMD Co. Ltd (133750) has total liabilities worth ₩16.86 Billion KRW (≈ $11.43 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 133750 operating cash flow to assess how effectively this company generates cash.

MegaMD Co. Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how MegaMD Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 133750 financial resilience to evaluate the company's liquid asset resilience ratio.

MegaMD Co. Ltd Competitors by Total Liabilities

The table below lists competitors of MegaMD Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Evaxion Biotech AS NASDAQ:EVAX	USA	$13.14 Million
Fathom Holdings Inc NASDAQ:FTHM	USA	$40.60 Million
Hitron Systems KO:019490	Korea	₩26.38 Billion
Nova Wellness Group Bhd KLSE:0201	Malaysia	RM8.54 Million
Tien Wah Press Holdings Bhd KLSE:7374	Malaysia	RM211.88 Million
Malmbergs Elektriska AB (publ) ST:MEAB-B	Sweden	Skr157.75 Million
Timberwell Bhd KLSE:7854	Malaysia	RM14.94 Million
Aarey Drugs & Pharmaceuticals Limited NSE:AAREYDRUGS	India	Rs1.45 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down MegaMD Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MegaMD Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MegaMD Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MegaMD Co. Ltd (2014–2025)

The table below shows the annual total liabilities of MegaMD Co. Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩16.86 Billion ≈ $11.43 Million	-21.95%
2024-12-31	₩21.61 Billion ≈ $14.64 Million	-3.82%
2023-12-31	₩22.47 Billion ≈ $15.23 Million	-19.21%
2022-12-31	₩27.81 Billion ≈ $18.85 Million	-42.03%
2021-12-31	₩47.97 Billion ≈ $32.51 Million	-6.35%
2020-12-31	₩51.23 Billion ≈ $34.71 Million	+0.52%
2019-12-31	₩50.96 Billion ≈ $34.54 Million	+19.61%
2018-12-31	₩42.61 Billion ≈ $28.87 Million	+24.43%
2017-12-31	₩34.24 Billion ≈ $23.21 Million	+19.18%
2016-12-31	₩28.73 Billion ≈ $19.47 Million	-0.43%
2015-12-31	₩28.86 Billion ≈ $19.56 Million	+42.98%
2014-12-31	₩20.18 Billion ≈ $13.68 Million	--

About MegaMD Co. Ltd

KQ:133750 Korea Education & Training Services

Market Cap

$28.00 Million

₩41.32 Billion KRW

Market Cap Rank

#23932 Global

#1731 in Korea

Share Price

₩1872.00

Change (1 day)

-1.21%

52-Week Range

₩1734.00 - ₩2460.00

All Time High

₩6608.13